SOTATERCEPT-CSRK

SOTATERCEPT-CSRK was reported 6188 times

SOTATERCEPT-CSRK is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 MICROVASCULAR INTRAPULMONARY SHUNT 19 0.9500
1 ACQUIRED ARTERIOVENOUS MALFORMATION 8 0.5000
2 PULMONARY ARTERIOVENOUS FISTULA 9 0.1579
3 MEDICAL DEVICE SITE ODOUR 3 0.1071
4 CATHETER SITE DISCOMFORT 7 0.0875
5 HAEMOGLOBIN INCREASED 315 0.0690
6 NON-PITTING OEDEMA 6 0.0682
7 BENDOPNOEA 14 0.0636
8 DEVICE MAINTENANCE ISSUE 30 0.0510
9 DIALYSIS HYPOTENSION 5 0.0505
10 RIGHT VENTRICULAR SYSTOLIC PRESSURE DECREASED 3 0.0492
11 CATHETER SITE SCAB 5 0.0467
12 TELANGIECTASIA 44 0.0456
13 UNEVALUABLE DEVICE ISSUE 4 0.0449
14 COR PULMONALE CHRONIC 8 0.0426
15 CATHETER SITE DISCOLOURATION 5 0.0410
16 ATRIAL SEPTAL DEFECT ACQUIRED 2 0.0385
17 VASCULAR DEVICE OCCLUSION 13 0.0383
18 PATIENT DISSATISFACTION WITH DEVICE 9 0.0357
19 DEVICE WIRELESS COMMUNICATION ISSUE 9 0.0347
20 INFUSION SITE INJURY 6 0.0341
21 ACQUIRED CARDIAC SEPTAL DEFECT 2 0.0339
22 MEDICAL DEVICE SITE ERYTHEMA 4 0.0312
23 ADMINISTRATION SITE WOUND 3 0.0303
24 CATHETER SITE PRURITUS 24 0.0273
25 INFUSION SITE HYPERSENSITIVITY 3 0.0250
26 DOSING ERROR 4 0.0238
27 INCREASED DOSE ADMINISTERED 7 0.0224
28 CATHETERISATION CARDIAC ABNORMAL 6 0.0222
29 INFUSION SITE INFECTION 51 0.0219
30 VENTILATION PERFUSION MISMATCH 6 0.0214
31 INFUSION SITE INFLAMMATION 15 0.0212
32 INFUSION SITE DISCHARGE 36 0.0205
33 INFUSION SITE SCAR 9 0.0203
34 ASPLENIA 2 0.0202
35 DEVICE INFUSION ISSUE 50 0.0201
36 OXYGEN CONSUMPTION INCREASED 48 0.0201
37 VASCULAR DEVICE INFECTION 90 0.0198
38 SPIDER VEIN 12 0.0188
39 POST-TUSSIVE VOMITING 3 0.0184
40 CATHETER SITE IRRITATION 6 0.0180
41 CATHETER SITE DISCHARGE 20 0.0178
42 ACUTE RIGHT VENTRICULAR FAILURE 3 0.0176
43 COLD FLASH 2 0.0172
44 VENTRICULAR ENLARGEMENT 3 0.0170
45 DRUG TITRATION ISSUE 3 0.0164
46 HAEMATOCRIT INCREASED 37 0.0162
47 SPIDER NAEVUS 3 0.0162
48 INFUSION SITE HAEMORRHAGE 52 0.0158
49 INFUSION SITE IRRITATION 20 0.0156
50 CATHETER SITE ERYTHEMA 33 0.0154
51 CATHETER SITE VESICLES 3 0.0154
52 WALKING DISTANCE TEST ABNORMAL 6 0.0153
53 CATHETER SITE SWELLING 14 0.0150
54 BLOOD VISCOSITY INCREASED 9 0.0149
55 CATHETER SITE HAEMORRHAGE 37 0.0148
56 CATHETER SITE THROMBOSIS 4 0.0146
57 GASTROINTESTINAL ANGIODYSPLASIA 6 0.0146
58 HYPERVOLAEMIA 71 0.0144
59 ADMINISTRATION SITE IRRITATION 2 0.0143
60 ALKALOSIS HYPOCHLORAEMIC 2 0.0143
61 INFUSION SITE ABSCESS 7 0.0139
62 INFUSION SITE WARMTH 17 0.0139
63 DEVICE CONNECTION ISSUE 29 0.0137
64 INFUSION SITE PAIN 176 0.0136
65 HEART FAILURE WITH PRESERVED EJECTION FRACTION 4 0.0136
66 RIGHT-TO-LEFT CARDIAC SHUNT 3 0.0135
67 CATHETER SITE RASH 6 0.0133
68 INFUSION SITE CELLULITIS 7 0.0133
69 DIZZINESS EXERTIONAL 10 0.0132
70 CATHETER SITE PAIN 34 0.0131
71 INFUSION SITE SWELLING 82 0.0130
72 INCREASED NEED FOR SLEEP 3 0.0129
73 INFUSION SITE ERYTHEMA 108 0.0128
74 NASAL CRUSTING 8 0.0123
75 CATHETER SITE BRUISE 4 0.0121
76 FULL BLOOD COUNT INCREASED 14 0.0118
77 SUTURE RUPTURE 8 0.0115
78 INFUSION SITE VESICLES 6 0.0114
79 DIALYSIS RELATED COMPLICATION 4 0.0113
80 PLEURAL DISORDER 7 0.0111
81 POLYCYTHAEMIA 22 0.0107
82 HAEMATOLOGICAL INFECTION 26 0.0106
83 CATHETER SITE INDURATION 2 0.0104
84 DYSPNOEA AT REST 30 0.0103
85 LEFT-TO-RIGHT CARDIAC SHUNT 3 0.0102
86 RIGHT VENTRICULAR ENLARGEMENT 3 0.0094
87 INFUSION SITE NODULE 9 0.0094
88 INFUSION SITE MASS 10 0.0092
89 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 56 0.0092
90 CAROTID ARTERY ANEURYSM 3 0.0088
91 INFUSION SITE REACTION 26 0.0087
92 SUTURE RELATED COMPLICATION 6 0.0085
93 PERICARDIAL EFFUSION 195 0.0084
94 COMPLICATIONS OF TRANSPLANTED LIVER 3 0.0083
95 ANGIODYSPLASIA 3 0.0082
96 DEPENDENCE ON OXYGEN THERAPY 4 0.0081
97 INFUSION SITE INDURATION 12 0.0081
98 INFUSION SITE RASH 11 0.0080
99 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 3 0.0080
100 INFUSION SITE DISCOLOURATION 7 0.0080
101 INFUSION SITE PRURITUS 25 0.0079
102 INJECTION SITE PUSTULE 3 0.0079
103 INFUSION SITE DISCOMFORT 8 0.0077
104 VASCULAR ACCESS COMPLICATION 6 0.0074
105 CENTRAL VENOUS CATHETERISATION 22 0.0073
106 DYSPNOEA EXERTIONAL 274 0.0073
107 RIGHT VENTRICULAR DYSFUNCTION 8 0.0073
108 EPISTAXIS 537 0.0072
109 DEVICE ALARM ISSUE 13 0.0072
110 PAIN IN JAW 200 0.0071
111 CATHETER SITE INFECTION 26 0.0069
112 DOSE CALCULATION ERROR 4 0.0068
113 PULMONARY ARTERIAL HYPERTENSION 96 0.0066
114 TRAUMATIC INTRACRANIAL HAEMORRHAGE 6 0.0065
115 CENTRAL VENOUS CATHETER REMOVAL 3 0.0064
116 PATIENT DISSATISFACTION WITH TREATMENT 12 0.0062
117 BLOOD VISCOSITY DECREASED 2 0.0060
118 COMPLICATION ASSOCIATED WITH DEVICE 85 0.0058
119 NASAL INFLAMMATION 6 0.0057
120 MEDICAL DEVICE CHANGE 3 0.0056
121 CATHETER MANAGEMENT 5 0.0056
122 VASCULAR INJURY 8 0.0055
123 MANUFACTURING PRODUCT SHIPPING ISSUE 3 0.0055
124 ARTERIOVENOUS MALFORMATION 5 0.0055
125 WEIGHT ABNORMAL 13 0.0054
126 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 3 0.0053
127 PRODUCT PREPARATION ISSUE 35 0.0053
128 MEDICAL DEVICE SITE PAIN 3 0.0053
129 BLOOD LOSS ANAEMIA 12 0.0053
130 INCREASED VISCOSITY OF UPPER RESPIRATORY SECRETION 4 0.0052
131 ADMINISTRATION SITE PAIN 6 0.0052
132 THERAPEUTIC PRODUCT EFFECT INCREASED 6 0.0052
133 HAEMOPERITONEUM 4 0.0050
134 CATHETERISATION CARDIAC 22 0.0050
135 DECREASED ACTIVITY 53 0.0049
136 DERMATITIS CONTACT 56 0.0049
137 CLUBBING 2 0.0049
138 ACOUSTIC NEUROMA 2 0.0049
139 OXYGEN THERAPY 8 0.0049
140 HAEMOGLOBIN ABNORMAL 31 0.0048
141 CARDITIS 2 0.0048
142 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
143 DRUG TITRATION ERROR 12 0.0046
144 PULMONARY HYPERTENSION 96 0.0046
145 LUNG TRANSPLANT 16 0.0045
146 THERAPY CHANGE 44 0.0045
147 PRODUCT RECONSTITUTION QUALITY ISSUE 4 0.0045
148 PULMONARY SARCOIDOSIS 5 0.0045
149 SCLERODERMA 16 0.0044
150 SEASONAL ALLERGY 61 0.0043
151 PULMONARY ARTERIAL PRESSURE INCREASED 7 0.0043
152 ADRENAL NEOPLASM 2 0.0043
153 PNEUMONIA INFLUENZAL 5 0.0042
154 INFUSION SITE BRUISING 9 0.0042
155 BLADDER CANCER RECURRENT 4 0.0040
156 CATHETER SITE RELATED REACTION 3 0.0040
157 RED BLOOD CELL COUNT INCREASED 11 0.0040
158 DEVICE POWER SOURCE ISSUE 11 0.0038
159 WEIGHT FLUCTUATION 39 0.0037
160 RIGHT VENTRICULAR FAILURE 26 0.0037
161 DIZZINESS POSTURAL 35 0.0036
162 JOINT INSTABILITY 5 0.0036
163 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0036
164 IRON DEFICIENCY 16 0.0036
165 INJECTION SITE DISCHARGE 19 0.0035
166 CONNECTIVE TISSUE DISORDER 5 0.0035
167 CRANIOFACIAL FRACTURE 3 0.0035
168 DEVICE RELATED SEPSIS 7 0.0035
169 PLATELET COUNT ABNORMAL 21 0.0035
170 NOROVIRUS INFECTION 5 0.0035
171 ARTERIAL STENOSIS 3 0.0034
172 OXYGEN SATURATION DECREASED 192 0.0034
173 DEVICE OCCLUSION 48 0.0034
174 CARDIOPULMONARY FAILURE 13 0.0033
175 CHRONIC RESPIRATORY FAILURE 4 0.0033
176 PURULENT DISCHARGE 14 0.0033
177 MUSCLE SWELLING 3 0.0033
178 DEVICE PHYSICAL PROPERTY ISSUE 25 0.0033
179 LARGE INTESTINE INFECTION 4 0.0033
180 ALLERGY TO CHEMICALS 4 0.0032
181 PRODUCT LEAKAGE 18 0.0032
182 PRODUCT ADMINISTRATION INTERRUPTED 25 0.0032
183 PRODUCT AFTER TASTE 3 0.0031
184 FLUID RETENTION 160 0.0031
185 CARDIAC VENTRICULAR THROMBOSIS 4 0.0031
186 RHINOVIRUS INFECTION 12 0.0031
187 PULMONARY PAIN 9 0.0031
188 INJECTION SITE INFECTION 10 0.0030
189 BRONCHITIS VIRAL 2 0.0030
190 CARBON DIOXIDE INCREASED 4 0.0029
191 INTERNAL HAEMORRHAGE 33 0.0029
192 MOUTH HAEMORRHAGE 21 0.0029
193 GINGIVAL BLEEDING 37 0.0027
194 AXILLARY PAIN 4 0.0027
195 GASTROINTESTINAL BACTERIAL INFECTION 3 0.0026
196 MUCOSAL HAEMORRHAGE 3 0.0026
197 NASAL DRYNESS 16 0.0026
198 DRUG TOLERANCE DECREASED 7 0.0025
199 PAINFUL RESPIRATION 6 0.0025
200 RECTAL PROLAPSE 3 0.0025
201 RESPIRATION ABNORMAL 17 0.0025
202 OXYGEN SATURATION ABNORMAL 7 0.0025
203 HAEMATOCRIT ABNORMAL 3 0.0024
204 ACNE PUSTULAR 2 0.0024
205 VASODILATATION 6 0.0024
206 HYPERAESTHESIA TEETH 3 0.0024
207 BLOOD IRON DECREASED 28 0.0024
208 THERAPY NON-RESPONDER 106 0.0024
209 LIP HAEMORRHAGE 3 0.0024
210 BLOOD TEST ABNORMAL 33 0.0023
211 TREATMENT DELAYED 4 0.0023
212 INTRA-ABDOMINAL FLUID COLLECTION 4 0.0022
213 BLOOD PRESSURE SYSTOLIC DECREASED 10 0.0022
214 DISCHARGE 3 0.0022
215 CATHETER PLACEMENT 4 0.0022
216 PRODUCT DISTRIBUTION ISSUE 20 0.0022
217 ECHOCARDIOGRAM ABNORMAL 3 0.0021
218 ANAL HAEMORRHAGE 6 0.0021
219 LABORATORY TEST ABNORMAL 63 0.0021
220 THERAPY PARTIAL RESPONDER 33 0.0021
221 HAEMOPTYSIS 59 0.0021
222 INCORRECT DRUG ADMINISTRATION RATE 9 0.0021
223 CARDIAC TAMPONADE 10 0.0021
224 FINE MOTOR SKILL DYSFUNCTION 6 0.0021
225 RESPIRATORY SYNCYTIAL VIRUS INFECTION 18 0.0021
226 HYPOXIA 72 0.0020
227 RENAL HAEMORRHAGE 4 0.0020
228 EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS 4 0.0020
229 BREAST ABSCESS 2 0.0020
230 DRUG DELIVERY SYSTEM MALFUNCTION 10 0.0020
231 MICROCYTIC ANAEMIA 4 0.0019
232 BRAIN FOG 30 0.0019
233 APPLICATION SITE PAPULES 2 0.0019
234 PARANASAL SINUS DISCOMFORT 7 0.0018
235 SHOULDER FRACTURE 3 0.0018
236 THROMBOSIS IN DEVICE 6 0.0018
237 MIDDLE EAR EFFUSION 4 0.0018
238 FLUSHING 184 0.0018
239 VENA CAVA THROMBOSIS 3 0.0018
240 THERAPEUTIC PRODUCT EFFECT VARIABLE 7 0.0018
241 DEVICE LEAKAGE 77 0.0018
242 DEVICE DISLOCATION 77 0.0018
243 GASTRIC POLYPS 4 0.0018
244 SENSITIVE SKIN 13 0.0018
245 THERAPY INTERRUPTED 125 0.0017
246 EXERCISE TOLERANCE DECREASED 10 0.0017
247 IRON DEFICIENCY ANAEMIA 16 0.0017
248 LOCALISED OEDEMA 8 0.0017
249 RALES 10 0.0017
250 ORAL SURGERY 4 0.0017
251 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO DEVICE USE ERROR 4 0.0017
252 CARDIAC ABLATION 3 0.0017
253 DEVICE PLACEMENT ISSUE 6 0.0017
254 BLEEDING TIME PROLONGED 2 0.0017
255 APPLICATION SITE HYPERSENSITIVITY 2 0.0016
256 CARDIAC FAILURE CHRONIC 7 0.0016
257 ESSENTIAL HYPERTENSION 3 0.0016
258 MEAN CELL HAEMOGLOBIN DECREASED 3 0.0016
259 DRUG DOSE TITRATION NOT PERFORMED 3 0.0016
260 BRAIN NATRIURETIC PEPTIDE INCREASED 5 0.0016
261 ABNORMAL LOSS OF WEIGHT 11 0.0016
262 AURA 3 0.0016
263 AMPUTATION 2 0.0016
264 NASAL OBSTRUCTION 3 0.0016
265 BLOOD IRON INCREASED 3 0.0016
266 PLATELET DISORDER 4 0.0016
267 PRODUCT STORAGE ISSUE 6 0.0016
268 UPPER-AIRWAY COUGH SYNDROME 13 0.0016
269 DEVICE RELATED INFECTION 24 0.0016
270 APPLICATION SITE EROSION 2 0.0016
271 SYRINGE ISSUE 27 0.0015
272 ABDOMINAL OPERATION 2 0.0015
273 PRODUCT PRESCRIBING ISSUE 33 0.0015
274 LIQUID PRODUCT PHYSICAL ISSUE 11 0.0015
275 ALLERGIC REACTION TO EXCIPIENT 3 0.0015
276 BLOOD POTASSIUM ABNORMAL 4 0.0015
277 SMALL INTESTINAL HAEMORRHAGE 3 0.0015
278 MUCOSAL DRYNESS 3 0.0015
279 EAR HAEMORRHAGE 3 0.0015
280 GASTROINTESTINAL HAEMORRHAGE 123 0.0015
281 EAR DISCOMFORT 15 0.0015
282 EYE CONTUSION 3 0.0014
283 PERIPHERAL SWELLING 216 0.0014
284 AFFECTIVE DISORDER 11 0.0014
285 HEART VALVE INCOMPETENCE 4 0.0014
286 NASAL CONGESTION 82 0.0014
287 COLONOSCOPY 3 0.0014
288 CARDIAC FAILURE ACUTE 9 0.0013
289 ARTHROPOD BITE 10 0.0013
290 SPINAL COLUMN INJURY 3 0.0013
291 PLATELET COUNT DECREASED 143 0.0013
292 SINUS CONGESTION 18 0.0013
293 INJECTION SITE VESICLES 8 0.0013
294 HEADACHE 826 0.0013
295 PARANASAL SINUS HYPERSECRETION 5 0.0013
296 FOOD POISONING 7 0.0013
297 THROAT IRRITATION 58 0.0013
298 PRODUCTIVE COUGH 61 0.0013
299 NONSPECIFIC REACTION 7 0.0013
300 OEDEMA 69 0.0013
301 SARCOIDOSIS 6 0.0013
302 INJECTION SITE IRRITATION 16 0.0013
303 ACUTE RESPIRATORY FAILURE 24 0.0012
304 ACUTE PULMONARY OEDEMA 7 0.0012
305 WRONG DOSE 3 0.0012
306 PERIORBITAL SWELLING 7 0.0012
307 PRESYNCOPE 30 0.0012
308 DYSPNOEA 698 0.0012
309 SYNCOPE 123 0.0012
310 PANCREATIC DISORDER 6 0.0012
311 PRODUCT PREPARATION ERROR 25 0.0012
312 BREATH SOUNDS ABNORMAL 6 0.0012
313 SELF-MEDICATION 5 0.0012
314 HOSPICE CARE 12 0.0012
315 BLOOD PRESSURE ABNORMAL 24 0.0012
316 HOSPITALISATION 185 0.0012
317 ARTHROPOD STING 2 0.0012
318 VENTRICULAR HYPERTROPHY 3 0.0012
319 SKIN LACERATION 13 0.0012
320 FEELING OF BODY TEMPERATURE CHANGE 7 0.0012
321 HEAD DISCOMFORT 21 0.0012
322 PRODUCT CONTAMINATION PHYSICAL 3 0.0012
323 HAEMORRHAGE URINARY TRACT 3 0.0012
324 APPENDICITIS 11 0.0012
325 HYPOTENSION 236 0.0012
326 BLOOD PRESSURE DECREASED 78 0.0012
327 POSTMENOPAUSAL HAEMORRHAGE 3 0.0011
328 EXFOLIATIVE RASH 3 0.0011
329 CHEST PAIN 210 0.0011
330 HAEMORRHAGIC DIATHESIS 4 0.0011
331 EAR CONGESTION 3 0.0011
332 DISEASE COMPLICATION 5 0.0011
333 RHINALGIA 3 0.0011
334 THERAPY CESSATION 56 0.0011
335 CHOKING SENSATION 6 0.0011
336 BODY TEMPERATURE ABNORMAL 2 0.0011
337 CHOLECYSTITIS INFECTIVE 3 0.0011
338 EXPOSURE VIA SKIN CONTACT 28 0.0011
339 HEART RATE ABNORMAL 6 0.0011
340 SINUS DISORDER 21 0.0011
341 PRODUCT CONTAINER ISSUE 9 0.0010
342 ILLNESS 108 0.0010
343 SUBDURAL HAEMATOMA 15 0.0010
344 ARTERIAL DISORDER 2 0.0010
345 UNINTENTIONAL MEDICAL DEVICE REMOVAL 12 0.0010
346 HUMERUS FRACTURE 5 0.0010
347 SKIN WARM 6 0.0010
348 OEDEMA PERIPHERAL 124 0.0010
349 DIZZINESS 504 0.0010
350 INJECTION SITE INFLAMMATION 5 0.0010
351 ANORECTAL DISORDER 2 0.0010
352 ATRIAL FLUTTER 8 0.0010
353 BLOOD CULTURE POSITIVE 3 0.0010
354 HAEMOGLOBIN DECREASED 102 0.0010
355 FUNGAL SKIN INFECTION 4 0.0010
356 DIARRHOEA 639 0.0010
357 SHOCK HAEMORRHAGIC 8 0.0010
358 COUGH 275 0.0010
359 SKIN INFECTION 11 0.0010
360 RECTAL HAEMORRHAGE 42 0.0010
361 MIGRAINE 93 0.0010
362 SECRETION DISCHARGE 12 0.0010
363 GASTRIC HAEMORRHAGE 11 0.0010
364 ASCITES 28 0.0010
365 SPUTUM DISCOLOURED 9 0.0009
366 GOUT 17 0.0009
367 INTENTIONAL DOSE OMISSION 27 0.0009
368 INJECTION SITE RASH 29 0.0009
369 RESPIRATORY TRACT CONGESTION 15 0.0009
370 PNEUMONIA VIRAL 3 0.0009
371 POOR PERIPHERAL CIRCULATION 4 0.0009
372 LEFT VENTRICULAR HYPERTROPHY 4 0.0009
373 ATELECTASIS 9 0.0009
374 SKIN EROSION 3 0.0009
375 CARDIAC FLUTTER 6 0.0009
376 PULMONARY THROMBOSIS 10 0.0009
377 MOOD ALTERED 25 0.0009
378 GENERAL PHYSICAL HEALTH DETERIORATION 106 0.0009
379 ASTHENOPIA 5 0.0009
380 DEAFNESS UNILATERAL 5 0.0009
381 DEVICE ISSUE 81 0.0009
382 DEVICE INFORMATION OUTPUT ISSUE 7 0.0009
383 HEART RATE INCREASED 89 0.0009
384 GENERALISED OEDEMA 11 0.0009
385 DRY THROAT 9 0.0009
386 NASAL DISCOMFORT 7 0.0009
387 SLUGGISHNESS 9 0.0009
388 NO ADVERSE EVENT 159 0.0009
389 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 15 0.0009
390 HYPERSOMNIA 25 0.0009
391 PRODUCT DOSE OMISSION ISSUE 253 0.0009
392 EXTRASYSTOLES 6 0.0009
393 ROSACEA 4 0.0009
394 PLATELET COUNT INCREASED 11 0.0008
395 SINUS HEADACHE 5 0.0008
396 SKIN WEEPING 3 0.0008
397 WEIGHT DECREASED 234 0.0008
398 DEVICE USE ERROR 29 0.0008
399 PHARYNGITIS STREPTOCOCCAL 9 0.0008
400 LIVER TRANSPLANT 3 0.0008
401 BRONCHITIS CHRONIC 2 0.0008
402 HAEMORRHOIDAL HAEMORRHAGE 4 0.0008
403 GASTROINTESTINAL PAIN 9 0.0008
404 SCIATICA 13 0.0008
405 MALNUTRITION 9 0.0008
406 DEVICE USE ISSUE 14 0.0008
407 HEART RATE DECREASED 28 0.0008
408 HAEMATOCHEZIA 44 0.0008
409 PRODUCT SOLUBILITY ABNORMAL 4 0.0008
410 PAIN IN EXTREMITY 233 0.0008
411 HEAD INJURY 25 0.0008
412 SUBARACHNOID HAEMORRHAGE 8 0.0008
413 CONJUNCTIVAL HAEMORRHAGE 3 0.0008
414 HEAVY MENSTRUAL BLEEDING 7 0.0008
415 LIMB INJURY 21 0.0008
416 REFUSAL OF TREATMENT BY PATIENT 5 0.0008
417 HAEMORRHAGE 80 0.0008
418 BLOOD POTASSIUM DECREASED 23 0.0008
419 CHEST DISCOMFORT 78 0.0008
420 IDIOPATHIC PULMONARY FIBROSIS 3 0.0008
421 SCRATCH 8 0.0008
422 PNEUMOTHORAX 12 0.0008
423 FULL BLOOD COUNT ABNORMAL 8 0.0008
424 TRICUSPID VALVE INCOMPETENCE 6 0.0008
425 RENAL PAIN 8 0.0008
426 EYE HAEMORRHAGE 10 0.0007
427 MUSCLE HAEMORRHAGE 3 0.0007
428 GASTROINTESTINAL MOTILITY DISORDER 4 0.0007
429 FLANK PAIN 7 0.0007
430 ULCER HAEMORRHAGE 5 0.0007
431 ABDOMINAL RIGIDITY 2 0.0007
432 APPLICATION SITE HAEMORRHAGE 2 0.0007
433 CARDIOMEGALY 9 0.0007
434 MELAENA 16 0.0007
435 GASTROINTESTINAL DISORDER 65 0.0007
436 RED CELL DISTRIBUTION WIDTH INCREASED 3 0.0007
437 PANCREATITIS 38 0.0007
438 PULMONARY OEDEMA 32 0.0007
439 JOINT SWELLING 86 0.0007
440 WEIGHT INCREASED 159 0.0007
441 BLOOD PRESSURE FLUCTUATION 17 0.0007
442 HEART RATE IRREGULAR 16 0.0007
443 FATIGUE 548 0.0007
444 PALPITATIONS 82 0.0007
445 CYANOSIS 11 0.0007
446 PRODUCT USE COMPLAINT 11 0.0007
447 TENSION HEADACHE 3 0.0007
448 CARDIOGENIC SHOCK 10 0.0007
449 BLOOD MAGNESIUM DECREASED 6 0.0007
450 SKIN ATROPHY 4 0.0007
451 INJECTION SITE ERYTHEMA 86 0.0007
452 FAECES DISCOLOURED 15 0.0007
453 ELECTROLYTE IMBALANCE 8 0.0007
454 CLOSTRIDIUM DIFFICILE INFECTION 15 0.0007
455 IMMOBILE 3 0.0007
456 DYSPEPSIA 67 0.0007
457 ABDOMINAL ABSCESS 3 0.0007
458 BACTERAEMIA 8 0.0007
459 PLEURAL EFFUSION 41 0.0007
460 ABDOMINAL DISCOMFORT 113 0.0007
461 HYPOACUSIS 29 0.0007
462 INJECTION SITE PRURITUS 45 0.0007
463 CARDIAC PACEMAKER INSERTION 4 0.0007
464 PRODUCT DOSE OMISSION IN ERROR 19 0.0007
465 SYMPTOM RECURRENCE 4 0.0007
466 OROPHARYNGEAL DISCOMFORT 6 0.0007
467 VIRAL INFECTION 22 0.0007
468 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 119 0.0007
469 URINE ABNORMALITY 3 0.0007
470 PNEUMONIA 213 0.0007
471 RASH MACULAR 23 0.0007
472 RETCHING 14 0.0007
473 IMMUNE THROMBOCYTOPENIA 3 0.0007
474 INSURANCE ISSUE 10 0.0007
475 INCREASED TENDENCY TO BRUISE 6 0.0007
476 PIGMENTATION DISORDER 4 0.0006
477 RASH PRURITIC 35 0.0006
478 NECK PAIN 36 0.0006
479 CARPAL TUNNEL SYNDROME 9 0.0006
480 DIARRHOEA HAEMORRHAGIC 6 0.0006
481 NAUSEA 507 0.0006
482 MULTIPLE ALLERGIES 5 0.0006
483 INJECTION SITE NODULE 7 0.0006
484 CARDIAC FAILURE 51 0.0006
485 SKIN ABRASION 3 0.0006
486 BLOOD URINE PRESENT 12 0.0006
487 SWELLING 59 0.0006
488 GINGIVAL PAIN 5 0.0006
489 DEVICE MALFUNCTION 44 0.0006
490 SUBCUTANEOUS ABSCESS 3 0.0006
491 SNEEZING 14 0.0006
492 RASH VESICULAR 3 0.0006
493 FRUSTRATION TOLERANCE DECREASED 5 0.0006
494 PRODUCT USE ISSUE 116 0.0006
495 GALLBLADDER DISORDER 11 0.0006
496 INJECTION SITE BRUISING 49 0.0006
497 CONTUSION 59 0.0006
498 POLYURIA 5 0.0006
499 INFLUENZA 68 0.0006
500 GASTROENTERITIS VIRAL 11 0.0006
501 SKIN HAEMORRHAGE 9 0.0006
502 ATRIAL FIBRILLATION 59 0.0006
503 CORONAVIRUS INFECTION 4 0.0006
504 ABDOMINAL DISTENSION 63 0.0006
505 RESPIRATORY DISORDER 18 0.0006
506 MENINGITIS 4 0.0006
507 LUNG DISORDER 29 0.0006
508 TOE AMPUTATION 3 0.0006
509 DEVICE DIFFICULT TO USE 39 0.0006
510 RIB FRACTURE 12 0.0006
511 TRISMUS 3 0.0006
512 JOINT EFFUSION 4 0.0006
513 DRUG INTOLERANCE 56 0.0006
514 CERVICAL VERTEBRAL FRACTURE 2 0.0006
515 LOCALISED INFECTION 14 0.0006
516 BLOOD CREATININE ABNORMAL 2 0.0006
517 LARGE INTESTINE POLYP 4 0.0006
518 PETECHIAE 6 0.0006
519 PRODUCT COMMUNICATION ISSUE 5 0.0006
520 ABNORMAL WEIGHT GAIN 7 0.0006
521 SYSTEMIC LUPUS ERYTHEMATOSUS 20 0.0006
522 FEAR OF INJECTION 4 0.0006
523 PRODUCT SUPPLY ISSUE 4 0.0006
524 FACIAL PAIN 5 0.0006
525 CEREBRAL HAEMORRHAGE 20 0.0006
526 GASTROINTESTINAL INFECTION 5 0.0006
527 DERMATITIS ALLERGIC 7 0.0006
528 PRODUCT RESIDUE PRESENT 3 0.0006
529 ANAL INCONTINENCE 5 0.0006
530 HIP SURGERY 3 0.0006
531 HAEMATEMESIS 14 0.0006
532 FAECES SOFT 4 0.0005
533 CARDIAC DISORDER 51 0.0005
534 VOMITING 256 0.0005
535 PRODUCT PHYSICAL CONSISTENCY ISSUE 3 0.0005
536 INJECTION SITE INJURY 3 0.0005
537 LOWER GASTROINTESTINAL HAEMORRHAGE 4 0.0005
538 HIATUS HERNIA 7 0.0005
539 DRUG EFFECT LESS THAN EXPECTED 8 0.0005
540 NERVE INJURY 6 0.0005
541 CARDIAC DYSFUNCTION 2 0.0005
542 HAEMORRHAGE INTRACRANIAL 8 0.0005
543 OCULAR DISCOMFORT 6 0.0005
544 DECREASED APPETITE 124 0.0005
545 PHOTOPHOBIA 10 0.0005
546 ORAL CANDIDIASIS 7 0.0005
547 EYE INFECTION 6 0.0005
548 FEELING ABNORMAL 126 0.0005
549 MYOCARDITIS 6 0.0005
550 LOSS OF CONSCIOUSNESS 67 0.0005
551 MOUTH SWELLING 3 0.0005
552 THYROID DISORDER 8 0.0005
553 HYPERVENTILATION 3 0.0005
554 DEVICE BREAKAGE 21 0.0005
555 POST PROCEDURAL HAEMORRHAGE 6 0.0005
556 STAPHYLOCOCCAL INFECTION 17 0.0005
557 AUTOIMMUNE DISORDER 5 0.0005
558 PULMONARY HAEMORRHAGE 4 0.0005
559 RESPIRATORY FAILURE 37 0.0005
560 LIGAMENT SPRAIN 5 0.0005
561 MENTAL STATUS CHANGES 14 0.0005
562 ODYNOPHAGIA 3 0.0005
563 APHONIA 7 0.0005
564 SPINAL FRACTURE 10 0.0005
565 POOR QUALITY DEVICE USED 5 0.0005
566 CELLULITIS 25 0.0005
567 NEURALGIA 12 0.0005
568 DERMATITIS ACNEIFORM 3 0.0005
569 TOOTH ABSCESS 5 0.0005
570 ADVERSE DRUG REACTION 44 0.0005
571 FEELING HOT 30 0.0005
572 MYALGIA 83 0.0005
573 EYE SWELLING 18 0.0005
574 INJECTION SITE SWELLING 37 0.0005
575 RHINORRHOEA 31 0.0005
576 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 34 0.0005
577 ATRIAL SEPTAL DEFECT 4 0.0005
578 PERICARDITIS 8 0.0005
579 SLEEP APNOEA SYNDROME 9 0.0005
580 INCREASED APPETITE 9 0.0005
581 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 22 0.0005
582 AORTIC VALVE INCOMPETENCE 2 0.0005
583 PULMONARY FIBROSIS 9 0.0005
584 ADVERSE EVENT 43 0.0005
585 CARDIAC OPERATION 4 0.0005
586 MUSCULOSKELETAL DISCOMFORT 8 0.0005
587 MUSCLE STRAIN 4 0.0005
588 HYSTERECTOMY 4 0.0005
589 NASOPHARYNGITIS 85 0.0005
590 CHAPPED LIPS 2 0.0005
591 RESPIRATORY TRACT INFECTION 12 0.0005
592 GASTROOESOPHAGEAL REFLUX DISEASE 37 0.0005
593 SEPSIS 51 0.0005
594 AMENORRHOEA 8 0.0005
595 HAEMATOCRIT DECREASED 9 0.0005
596 GAIT INABILITY 15 0.0004
597 PRODUCT PHYSICAL ISSUE 9 0.0004
598 BRONCHIECTASIS 3 0.0004
599 PANCREATITIS ACUTE 10 0.0004
600 ASTHENIA 167 0.0004
601 OROPHARYNGEAL PAIN 41 0.0004
602 INJECTION SITE PAIN 135 0.0004
603 ABDOMINAL HERNIA 2 0.0004
604 THROMBOCYTOPENIA 49 0.0004
605 HOT FLUSH 33 0.0004
606 MICTURITION URGENCY 5 0.0004
607 INJECTION SITE WARMTH 9 0.0004
608 SKIN DISCOLOURATION 20 0.0004
609 THROMBOSIS 35 0.0004
610 BACK PAIN 101 0.0004
611 ABDOMINAL PAIN UPPER 89 0.0004
612 BLOOD POTASSIUM INCREASED 7 0.0004
613 SWELLING FACE 28 0.0004
614 RENAL DISORDER 20 0.0004
615 INFECTION 62 0.0004
616 ERYTHEMA 88 0.0004
617 INJECTION SITE HAEMORRHAGE 34 0.0004
618 HAND FRACTURE 3 0.0004
619 DEHYDRATION 56 0.0004
620 CHOLECYSTITIS 5 0.0004
621 LOWER LIMB FRACTURE 8 0.0004
622 SKIN IRRITATION 19 0.0004
623 NEEDLE ISSUE 12 0.0004
624 EAR PAIN 8 0.0004
625 UPPER RESPIRATORY TRACT INFECTION 19 0.0004
626 UTERINE LEIOMYOMA 3 0.0004
627 VITAMIN D DEFICIENCY 4 0.0004
628 PHARYNGEAL SWELLING 4 0.0004
629 FLATULENCE 23 0.0004
630 PULMONARY MASS 6 0.0004
631 INABILITY TO AFFORD MEDICATION 4 0.0004
632 ABDOMINAL TENDERNESS 2 0.0004
633 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 21 0.0004
634 ORAL PAIN 9 0.0004
635 ANEURYSM 2 0.0004
636 GENERAL SYMPTOM 3 0.0004
637 COVID-19 70 0.0004
638 RASH ERYTHEMATOUS 19 0.0004
639 COLD SWEAT 7 0.0004
640 FULL BLOOD COUNT DECREASED 8 0.0004
641 UNEVALUABLE EVENT 30 0.0004
642 DYSPHONIA 23 0.0004
643 AMMONIA INCREASED 2 0.0004
644 PROCEDURAL COMPLICATION 3 0.0004
645 DEVICE ADHESION ISSUE 6 0.0004
646 FALL 129 0.0004
647 EJECTION FRACTION DECREASED 6 0.0004
648 VISION BLURRED 53 0.0004
649 TRANSIENT ISCHAEMIC ATTACK 13 0.0004
650 PELVIC FRACTURE 3 0.0004
651 RESTLESS LEGS SYNDROME 7 0.0004
652 TRANSFUSION 4 0.0004
653 ARTHRALGIA 157 0.0004
654 EAR INFECTION 10 0.0004
655 BACTERIAL INFECTION 7 0.0004
656 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 18 0.0004
657 HIP FRACTURE 12 0.0004
658 PAIN 229 0.0004
659 POOR QUALITY SLEEP 8 0.0004
660 SINUSITIS 38 0.0004
661 MUSCLE TIGHTNESS 6 0.0004
662 BACK DISORDER 6 0.0004
663 MALAISE 161 0.0004
664 OESOPHAGITIS 4 0.0004
665 LETHARGY 21 0.0004
666 ERUCTATION 7 0.0004
667 ABDOMINAL PAIN 84 0.0004
668 HEMIPLEGIA 3 0.0004
669 POLLAKIURIA 15 0.0004
670 HUNGER 5 0.0004
671 CHOKING 7 0.0004
672 ANGIOPATHY 2 0.0004
673 UPPER GASTROINTESTINAL HAEMORRHAGE 6 0.0004
674 CANDIDA INFECTION 6 0.0004
675 DIALYSIS 5 0.0004
676 SCAB 4 0.0004
677 TACHYCARDIA 31 0.0003
678 SHOCK 8 0.0003
679 HAEMATOMA 9 0.0003
680 DRY MOUTH 28 0.0003
681 JOINT STIFFNESS 9 0.0003
682 GASTRITIS 9 0.0003
683 CHILLS 40 0.0003
684 RASH 148 0.0003
685 CARDIOMYOPATHY 5 0.0003
686 RESPIRATORY RATE INCREASED 3 0.0003
687 WHEEZING 20 0.0003
688 NEUROPATHY PERIPHERAL 32 0.0003
689 THIRST 6 0.0003
690 FREQUENT BOWEL MOVEMENTS 9 0.0003
691 HYPOAESTHESIA ORAL 5 0.0003
692 ANXIETY 94 0.0003
693 LIP DRY 3 0.0003
694 TREATMENT NONCOMPLIANCE 18 0.0003
695 INCORRECT DOSE ADMINISTERED 75 0.0003
696 PNEUMONIA BACTERIAL 3 0.0003
697 RETINAL DETACHMENT 3 0.0003
698 DIVERTICULITIS 9 0.0003
699 CARDIAC FAILURE CONGESTIVE 26 0.0003
700 MUSCULOSKELETAL CHEST PAIN 5 0.0003
701 WOUND 9 0.0003
702 APPLICATION SITE IRRITATION 4 0.0003
703 HEPATIC CIRRHOSIS 6 0.0003
704 URINARY TRACT INFECTION 54 0.0003
705 FOOT FRACTURE 6 0.0003
706 CONSTIPATION 69 0.0003
707 MUSCLE ATROPHY 4 0.0003
708 ABSCESS 5 0.0003
709 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
710 WHITE BLOOD CELL COUNT INCREASED 12 0.0003
711 POST PROCEDURAL COMPLICATION 6 0.0003
712 ANAEMIA 59 0.0003
713 HAEMORRHOIDS 6 0.0003
714 KIDNEY INFECTION 6 0.0003
715 ARTHRITIS 24 0.0003
716 BEDRIDDEN 4 0.0003
717 PULMONARY CONGESTION 4 0.0003
718 APPETITE DISORDER 2 0.0003
719 VISUAL IMPAIRMENT 37 0.0003
720 PRODUCT ADMINISTRATION ERROR 6 0.0003
721 FACE OEDEMA 5 0.0003
722 ILL-DEFINED DISORDER 18 0.0003
723 FEEDING DISORDER 6 0.0003
724 TASTE DISORDER 6 0.0003
725 PNEUMONITIS 8 0.0003
726 IMPAIRED GASTRIC EMPTYING 4 0.0003
727 CORONARY ARTERY OCCLUSION 4 0.0003
728 PERIPHERAL COLDNESS 4 0.0003
729 APPLICATION SITE RASH 4 0.0003
730 COLITIS 11 0.0003
731 ACNE 22 0.0003
732 BALANCE DISORDER 25 0.0003
733 VENTRICULAR EXTRASYSTOLES 3 0.0003
734 PROCEDURAL PAIN 8 0.0003
735 ORTHOSTATIC HYPOTENSION 5 0.0003
736 INJECTION SITE DISCOMFORT 3 0.0003
737 APPLICATION SITE REACTION 2 0.0003
738 DRUG ERUPTION 5 0.0003
739 HYPOKALAEMIA 13 0.0003
740 JOINT INJURY 6 0.0003
741 AGEUSIA 7 0.0003
742 RED BLOOD CELL COUNT DECREASED 8 0.0003
743 PARAESTHESIA 44 0.0003
744 SEPTIC SHOCK 12 0.0003
745 APATHY 4 0.0003
746 HYPOPHAGIA 7 0.0003
747 ACCIDENTAL EXPOSURE TO PRODUCT 28 0.0003
748 BLINDNESS TRANSIENT 2 0.0003
749 INJECTION SITE MASS 10 0.0003
750 BRONCHITIS 20 0.0003
751 CONJUNCTIVITIS 5 0.0003
752 INTERSTITIAL LUNG DISEASE 13 0.0003
753 APPLICATION SITE ERYTHEMA 7 0.0003
754 LACRIMATION INCREASED 8 0.0003
755 CONDITION AGGRAVATED 80 0.0003
756 DEVICE FAILURE 4 0.0003
757 VERTIGO 16 0.0003
758 ACIDOSIS 2 0.0003
759 HYPOAESTHESIA 39 0.0003
760 GLAUCOMA 5 0.0003
761 HERNIA 5 0.0003
762 ANKLE FRACTURE 4 0.0003
763 URTICARIA 43 0.0003
764 MUSCLE SPASMS 47 0.0003
765 SKIN FISSURES 5 0.0003
766 DEVICE DELIVERY SYSTEM ISSUE 7 0.0003
767 INFLUENZA LIKE ILLNESS 21 0.0003
768 PYREXIA 88 0.0003
769 LYMPHADENOPATHY 9 0.0003
770 COVID-19 PNEUMONIA 3 0.0003
771 ARRHYTHMIA 12 0.0003
772 WRIST FRACTURE 3 0.0003
773 ADRENAL INSUFFICIENCY 3 0.0002
774 NOCTURIA 3 0.0002
775 EXTRA DOSE ADMINISTERED 10 0.0002
776 DEPRESSED MOOD 13 0.0002
777 PRURITUS 94 0.0002
778 SPINAL OPERATION 3 0.0002
779 HYPERCALCAEMIA 3 0.0002
780 INJECTION SITE DISCOLOURATION 3 0.0002
781 COAGULOPATHY 4 0.0002
782 TINNITUS 11 0.0002
783 ROAD TRAFFIC ACCIDENT 10 0.0002
784 POISONING 3 0.0002
785 INTRAOCULAR PRESSURE INCREASED 3 0.0002
786 INJECTION SITE INDURATION 3 0.0002
787 NERVOUSNESS 12 0.0002
788 EOSINOPHILIA 4 0.0002
789 IMMUNE SYSTEM DISORDER 3 0.0002
790 APPLICATION SITE PAIN 5 0.0002
791 QUALITY OF LIFE DECREASED 3 0.0002
792 BONE PAIN 13 0.0002
793 PULMONARY EMBOLISM 21 0.0002
794 TOOTHACHE 4 0.0002
795 OSTEOMYELITIS 4 0.0002
796 RESPIRATORY DISTRESS 6 0.0002
797 MUSCULOSKELETAL STIFFNESS 19 0.0002
798 FEELING COLD 6 0.0002
799 HYPOMAGNESAEMIA 3 0.0002
800 MASS 3 0.0002
801 MIDDLE INSOMNIA 4 0.0002
802 SLEEP DISORDER 15 0.0002
803 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
804 FRACTURE 4 0.0002
805 TREMOR 35 0.0002
806 OCULAR HYPERAEMIA 10 0.0002
807 GASTRIC ULCER 4 0.0002
808 BRONCHOSPASM 3 0.0002
809 BLOOD PRESSURE INCREASED 32 0.0002
810 HERPES ZOSTER 12 0.0002
811 HYPERTHYROIDISM 3 0.0002
812 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
813 HYPERSENSITIVITY 38 0.0002
814 SURGERY 12 0.0002
815 HAEMATURIA 7 0.0002
816 BODY TEMPERATURE DECREASED 2 0.0002
817 DEATH 174 0.0002
818 BLADDER DISORDER 2 0.0002
819 PNEUMONIA ASPIRATION 5 0.0002
820 BLOOD CREATININE INCREASED 13 0.0002
821 HYPERHIDROSIS 25 0.0002
822 FEMUR FRACTURE 6 0.0002
823 MUSCULAR WEAKNESS 22 0.0002
824 GAIT DISTURBANCE 37 0.0002
825 DIPLOPIA 5 0.0002
826 DEAFNESS 5 0.0002
827 SEIZURE 22 0.0002
828 HYPERTENSION 40 0.0002
829 ULCER 3 0.0002
830 OBESITY 3 0.0002
831 EATING DISORDER 4 0.0002
832 LIVER FUNCTION TEST INCREASED 4 0.0002
833 INTESTINAL OBSTRUCTION 7 0.0002
834 THROAT TIGHTNESS 5 0.0002
835 VAGINAL HAEMORRHAGE 8 0.0002
836 BIPOLAR DISORDER 2 0.0002
837 PRODUCT STORAGE ERROR 16 0.0002
838 ASPIRATION 2 0.0002
839 PHOTOSENSITIVITY REACTION 3 0.0002
840 SKIN BURNING SENSATION 13 0.0002
841 RASH MACULO-PAPULAR 4 0.0002
842 GLOSSODYNIA 4 0.0002
843 BLOOD CALCIUM DECREASED 2 0.0002
844 EYE PAIN 10 0.0002
845 APPLICATION SITE PRURITUS 4 0.0002
846 PRODUCT AVAILABILITY ISSUE 4 0.0002
847 SCAR 3 0.0002
848 CHOLECYSTECTOMY 2 0.0002
849 INFLAMMATION 9 0.0002
850 DEVICE DEFECTIVE 3 0.0002
851 DYSSTASIA 5 0.0002
852 COMA 8 0.0002
853 ACCIDENT 2 0.0002
854 PANIC ATTACK 6 0.0002
855 UNDERDOSE 12 0.0002
856 DISCOMFORT 10 0.0002
857 INJECTION SITE URTICARIA 4 0.0002
858 DEPRESSION 37 0.0002
859 LIMB DISCOMFORT 5 0.0002
860 CONFUSIONAL STATE 26 0.0002
861 MENTAL DISORDER 7 0.0002
862 BLOOD SODIUM DECREASED 3 0.0002
863 BURNING SENSATION 11 0.0002
864 METABOLIC ACIDOSIS 5 0.0002
865 NIGHT SWEATS 5 0.0002
866 UNRESPONSIVE TO STIMULI 4 0.0002
867 SKIN ULCER 4 0.0002
868 INSOMNIA 41 0.0002
869 CEREBROVASCULAR ACCIDENT 26 0.0002
870 MEMORY IMPAIRMENT 21 0.0002
871 NEPHROLITHIASIS 7 0.0002
872 CHOLELITHIASIS 5 0.0002
873 IMPAIRED HEALING 5 0.0002
874 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
875 UPPER LIMB FRACTURE 3 0.0002
876 FUNGAL INFECTION 5 0.0001
877 DRY SKIN 20 0.0001
878 SOMNOLENCE 30 0.0001
879 EYE PRURITUS 5 0.0001
880 PAIN OF SKIN 4 0.0001
881 INJURY ASSOCIATED WITH DEVICE 3 0.0001
882 BODY TEMPERATURE INCREASED 3 0.0001
883 PALLOR 4 0.0001
884 RENAL FAILURE 19 0.0001
885 BLISTER 8 0.0001
886 BLINDNESS UNILATERAL 2 0.0001
887 SKIN CANCER 3 0.0001
888 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
889 ACUTE KIDNEY INJURY 21 0.0001
890 ACCIDENTAL OVERDOSE 5 0.0001
891 COLON CANCER 2 0.0001
892 RASH PAPULAR 3 0.0001
893 THERAPEUTIC RESPONSE UNEXPECTED 6 0.0001
894 CARDIAC ARREST 11 0.0001
895 BONE LOSS 2 0.0001
896 CONTRAINDICATED PRODUCT ADMINISTERED 4 0.0001
897 MUSCLE TWITCHING 3 0.0001
898 EMOTIONAL DISORDER 4 0.0001
899 OFF LABEL USE 113 0.0001
900 DYSPHAGIA 12 0.0001
901 MOOD SWINGS 4 0.0001
902 MOBILITY DECREASED 9 0.0001
903 DYSKINESIA 5 0.0001
904 MYOCARDIAL INFARCTION 21 0.0001
905 SKIN DISORDER 4 0.0001
906 CARDIO-RESPIRATORY ARREST 5 0.0001
907 BLOOD UREA INCREASED 2 0.0001
908 ABDOMINAL PAIN LOWER 3 0.0001
909 SKIN EXFOLIATION 10 0.0001
910 CATARACT 7 0.0001
911 HEPATIC ENZYME INCREASED 8 0.0001
912 OVERDOSE 25 0.0001
913 RHEUMATOID ARTHRITIS 13 0.0001
914 INCORRECT DOSE ADMINISTERED BY DEVICE 3 0.0001
915 LIVER DISORDER 5 0.0001
916 PRODUCT ADHESION ISSUE 4 0.0001
917 CRYING 4 0.0001
918 RESTLESSNESS 4 0.0001
919 DYSURIA 4 0.0001
920 BLOOD GLUCOSE ABNORMAL 2 0.0001
921 ANGINA PECTORIS 3 0.0001
922 PRODUCT SUBSTITUTION ISSUE 6 0.0001
923 PANCREATIC CARCINOMA 3 0.0001
924 INJECTION SITE REACTION 7 0.0001
925 PSYCHOTIC DISORDER 3 0.0001
926 URINARY INCONTINENCE 3 0.0001
927 DISORIENTATION 4 0.0001
928 PRODUCT USE IN UNAPPROVED INDICATION 25 0.0001
929 DRY EYE 5 0.0001
930 ABORTION SPONTANEOUS 4 0.0001
931 CORONARY ARTERY DISEASE 3 0.0001
932 BLINDNESS 4 0.0001
933 OSTEOPOROSIS 4 0.0001
934 ALOPECIA 19 0.0001
935 SWOLLEN TONGUE 3 0.0001
936 SPEECH DISORDER 5 0.0001
937 BRADYCARDIA 5 0.0001
938 DYSGEUSIA 7 0.0001
939 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 19 0.0001
940 HALLUCINATION 7 0.0001
941 EYE DISORDER 3 0.0001
942 ANAPHYLACTIC REACTION 5 0.0001
943 EXPIRED PRODUCT ADMINISTERED 3 0.0001
944 LIP SWELLING 3 0.0001
945 NEOPLASM MALIGNANT 6 0.0001
946 TYPE 2 DIABETES MELLITUS 3 0.0001
947 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
948 CHROMATURIA 2 0.0001
949 ASTHMA 10 0.0001
950 EYE IRRITATION 5 0.0001
951 BLOOD CHOLESTEROL INCREASED 4 0.0001
952 DISEASE PROGRESSION 10 0.0001
953 RENAL IMPAIRMENT 7 0.0001
954 BLOOD GLUCOSE DECREASED 4 0.0001
955 HYPERGLYCAEMIA 3 0.0001
956 DRUG INTERACTION 13 0.0001
957 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
958 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
959 DYSARTHRIA 3 0.0001
960 DRUG INEFFECTIVE 104 0.0001
961 CARDIOVASCULAR DISORDER 2 0.0001
962 MATERNAL EXPOSURE DURING PREGNANCY 7 0.0001
963 DEEP VEIN THROMBOSIS 5 0.0001
964 ASPARTATE AMINOTRANSFERASE INCREASED 4 0.0001
965 BREAST CANCER FEMALE 2 0.0001
966 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
967 LUNG NEOPLASM MALIGNANT 3 0.0001
968 ABNORMAL DREAMS 2 0.0001
969 ARTHROPATHY 4 0.0001
970 AGITATION 5 0.0001
971 ACUTE MYOCARDIAL INFARCTION 2 0.0001
972 IRRITABILITY 4 0.0001
973 THERAPEUTIC RESPONSE DECREASED 4 0.0001
974 STOMATITIS 4 0.0001
975 DIABETES MELLITUS 5 0.0001
976 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
977 PROSTATE CANCER 5 0.0001
978 HYPOGLYCAEMIA 3 0.0001
979 AMNESIA 4 0.0001
980 ECZEMA 3 0.0001
981 INTENTIONAL PRODUCT MISUSE 5 0.0001
982 DERMATITIS ATOPIC 3 0.0001
983 BREAST CANCER 5 0.0001
984 DRUG DOSE OMISSION BY DEVICE 4 0.0001
985 EXPOSURE DURING PREGNANCY 3 0.0000
986 BLOOD GLUCOSE INCREASED 9 0.0000
987 ANGIOEDEMA 2 0.0000
988 COGNITIVE DISORDER 2 0.0000
989 CHRONIC KIDNEY DISEASE 3 0.0000
990 BLADDER CANCER 2 0.0000
991 EMOTIONAL DISTRESS 4 0.0000
992 PRODUCT QUALITY ISSUE 4 0.0000